Уважаемые коллеги, доброго времени суток! Представляем вам немецкое научное издание Aging clinical and experimental research. Журнал имеет второй квартиль, издаётся в Springer Verlag, его SJR за 2021 г. равен 0,911, пятилетний импакт-фактор 4,075, электронный ISSN - 1720-8319, предметные области - Гериатрия и геронтология, Старение. Вот так выглядит обложка:
Редактором является Стефания Магги, контактные данные - stefania.maggi@in.cnr.it.
Дополнительные публикационные контакты - sankari.gireesa@springernature.com, Muralidaran.Govindaswamy@springer.com, journalpermissions@springernature.com, valentina.corio@springer.com.
Журнал предлагает междисциплинарный форум по развивающейся области геронтологии и гериатрии. Области, охватываемые журналом, включают: биогеронтологию, неврологию, эпидемиологию, клиническую геронтологию и гериатрическую оценку, социальную, экономическую и поведенческую геронтологию. Он выходит раз в два месяца и публикует обзорные статьи, оригинальные статьи и тематические отчеты.
Адрес издания - https://www.springer.com/journal/40520
Пример статьи, название - Development and validation of an intrinsic capacity composite score in the Longitudinal Aging Study Amsterdam: a formative approach. Заголовок (Abstract)
Background
Intrinsic capacity (IC) defined by the WHO refers to the composite of five domains of capacities. So far, developing and validating a standardized overall score of the concept have been challenging partly because its conceptual framework has been unclear. We consider that a person’s IC is determined by its domain-specific indicators suggesting a formative measurement model.
Aims
To develop an IC score applying a formative approach and assess its validity.
Methods
The study sample (n = 1908) consisted of 57–88-year-old participants from the Longitudinal Aging Study Amsterdam (LASA). We used logistic regression models to select the indicators to the IC score with 6-year functional decline as an outcome. An IC score (range 0–100) was constructed for each participant. We examined the known-groups’ validity of the IC score by comparing groups based on age and number of chronic diseases. The criterion validity of the IC score was assessed with 6-year functional decline and 10-year mortality as outcomes.
Results
The constructed IC score included seven indicators covering all five domains of the construct. The mean IC score was 66.7 (SD 10.3). The scores were higher among younger participants and those who had lower number of chronic diseases. After adjustment for sociodemographic indicators, chronic diseases, and BMI, a one-point higher IC score was associated with a 7% decreased risk for 6-year functional decline and a 2% decreased risk for 10-year mortality.
Conclusions
The developed IC score demonstrated discriminative ability according to age and health status and is associated with subsequent functional decline and mortality.